What You Should Know:
Home-based care provider Tomorrow Health announced its decision to shutter its first-party home medical equipment (HME) supply business to remove barriers and unlock new opportunities for its network of home-based care providers.Tomorrow Health’s decision to concentrate its focus on technology for supplier partners comes as the broader healthcare ecosystem shifts its strategic priorities and seeks greater support in enabling the delivery and reimbursement of quality
Read More
Artelon Secures $20M to Advance Surgical Treatment of Joint Instability
What You Should Know:
Artelon Inc., a privately held medical device company raises $20M in Series B funding, led by Vensana Capital with expected additional participation from existing investors. Artelon's Dynamic Matrix technology is a proprietary polymeric bio-textile for musculoskeletal soft tissue reconstruction designed to mimic the natural mechanical and biological properties of healing ligament tissue. It has been proven in clinical studies to protect the surgical repair
Read More
Denials Management Named Most Time-Consuming Task in RCM
What You Should Know:
A new HFMA survey commissioned by AKASA highlights the revenue cycle tasks requiring the most subject matter expertise, according to responses from over 550 CFOs and revenue cycle leaders at hospitals and health systems across the U.S.Denials management not only requires the most subject matter expertise, but it’s also the most time-consuming task within revenue cycle management (RCM) — followed by prior authorization and insurance
Read More
Q/A: IQVIA’s Global Lead Talks Unlocking AI for Drug Repurposing
In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing is transforming pharma and biotech companies.
What are some of the challenges and problems associated with drug discovery “from scratch”?
Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA: In the traditional drug discovery and development paradigm, it can cost up to $1.8 billion and
Read More
5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal
We recently asked five digital health executives to share their insights on the recent Kaiser's recent acquisition of Geisinger Health and it's impact to accelerate value-based care.
Andy Flanagan, CEO of Iris Telehealth
This acquisition presents a significant upside for the industry's move to improve access to quality, affordable care. Kaiser and Geisinger are two of the premier organizations in our country driving towards value-based care at scale for their communities. The creation
Read More
BVP Forge Invests in Quality Management Platform, Medisolv
What You Should Know:
Private equity firm BVP Forge has completed a strategic investment in Medisolv, a healthcare quality data measurement and reporting solution, to accelerate its growth. BVP Forge will also provide Medisolv access to the growth IP, talent network, and resources of Bessemer Venture Partners.Medisolv was founded in 1999 with the idea that software can unlock the intelligence buried in the chaos of healthcare data. Medisolv will benefit from ForgeEdge™, BVP Forge’s
Read More
German Digital Health Startup Patient21 Secures $108M to Transform Primary Care
What You Should Know:
Patient21, a Berlin, Germany-based digital health startup raises has successfully raised €100m ($108M) in Series C funding from investors Pitango, Target Global, Piton Capital, PICO Venture Partners , Bertelsmann Investments, and Artian Investments Limited.Founded in 2019, Patient21 provides mix of brick-and-mortar primary care clinics and a digital health platform for online booking, check-in and insurance.The company plans to use the
Read More
Digital Health Executive Hires & Departures: Ed Marx Departure, Particle Health CEO, Rhapsody CFO, Others
Health IT veteran Ed Marx announces his departure as CEO at Divurgent to launch his advisory company, Marx Advisory focused on helping healthcare executives & organizations achieve objectives and key results.
Particle Health appointed Jason Prestinario as its next CEO, effective today. Troy Bannister, founder and current CEO, will continue with Particle as Chief Strategy Officer, where he will spearhead product innovation.
Rhapsody names Jeff Chiumiento as the company’s new
Read More
Roundups: Tampa General, Henry Ford, PatientsLikeMe, Other Digital Health Partnerships
Tampa General Hospital Teams Up with Navina
Tampa General Hospital (TGH) partners with AI-powered platform Navina to bring its transformative AI the health system's primary care clinicians. Navina's AI takes large amounts of patient data, including information from labs, consult notes, imaging and more to help create a concise picture of a patient's health status that is instantly understandable and actionable. Clinicians using Navina's platform can quickly assess diagnoses and
Read More
HealthSnap Secures $9M for Remote Patient Monitoring Platform
What You Should Know:
HealthSnap, a Miami-based remote patient monitoring platform for chronic disease management raises $9M in funding led by Asclepius Growth Capital, an SPV founded by David Jahns, a managing director of Galen Partners, and Steve Cashman, CEO of Caption Health and former CCO of InTouch Health, as well as new strategic investments from current business partners UnityPoint Health and Tampa General Hospital. Existing stockholders Florida Funders and MacDonald Ventures also
Read More
